Out of all the cannabis stocks on the market, this one is at the very top of Goodness Growth CEO Kyle Kingsley’s list…
When Vireo Health International Inc. rebranded to Goodness Growth Holdings Inc. (OTC: GDNSF) last month, CEO Kyle Kingsley, M.D. had more than just a name change in mind.
He wanted to reflect the company’s pivot from a strictly medical cannabis operator to a more all-encompassing approach to health care – including a new branch into one of the most exciting up-and-coming industries since cannabis emerged on the scene.
Just in the past couple of years, psychedelics have quickly transformed from a fringe sector of holistic medicine to a legitimate $3.8 billion pharmaceutical industry backed by venture capital heavyweights like Peter Thiel – one projected to surge as much as 181% to $10.7 billion by 2028.
Dr. Kingsley was one of the first cannabis execs to recognize that opportunity, and has already filed a patent to develop a virtual reality application for psychedelic-based therapies through Goodness Growth’s subsidiary, Resurgent Biosciences.
Clearly this guy has his finger on the pulse of moneymaking opportunities. So, naturally, I wanted to find out where he would invest his own money in cannabis stocks.
Keep watching In the Green for more stock picks from industry legends like Bruce Linton, Fabian Monaco, Aaron Miles, and more by clicking here.
And no investor’s portfolio is complete without the latest list of “Buy This, Not That” stock picks from my good friend and colleague, Shah Gilani.
Make sure you get his recommendations right here.
Executive Director, National Institute for Cannabis Investors
3 responses to “In the Green Episode 7: Other Than Goodness Growth, There’s Only One Cannabis Stock at the Top of CEO Kyle Kingsley’s “Buy” List”
July 27 2021